Cantor Fitzgerald initiated coverage on Materialise with a new price target
$MTLS
Computer Software: Prepackaged Software
Technology
Cantor Fitzgerald initiated coverage of Materialise with a rating of Overweight and set a new price target of $9.50
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/24/2024 | $9.50 | Overweight | Cantor Fitzgerald |
| 5/26/2023 | $11.00 | Hold → Buy | Kepler |
| 3/25/2022 | $20.00 | Buy → Neutral | Bryan Garnier |
| 10/20/2021 | $28.00 | Overweight | JP Morgan |
| 9/2/2021 | $30.00 | Buy | Stifel |
| 8/9/2021 | $30.00 | Buy | Lake Street |
6-K - MATERIALISE NV (0001091223) (Filer)
6-K - MATERIALISE NV (0001091223) (Filer)
6-K - MATERIALISE NV (0001091223) (Filer)
Regulated information1 Materialise NV ((Euronext &, NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Materialise Medical segment. Gross profit as a percentage of revenue for the fourth quarter of 2025 increased to 58.1%, compared to 55.4% for the corresponding 2024 period. Adjusted EBIT amounted to 3,98
Materialise NV ((Euronext &, NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the fourth quarter ended December 31, 2025 on Thursday, February 19, 2026 at 2:30 a.m. ET/8:30 a.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2025 financial results on Thursday, February 19, 2026 at 8:30 a.m. ET/1:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a
THIS ANNOUNCEMENT IS NOT DIRECTED AT OR INTENDED TO BE DISTRIBUTED TO PERSONS WHO ARE CITIZEN OR RESIDENT OF OR LOCATED IN SWITZERLAND, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THIS ANNOUNCEMENT WOULD BREACH ANY APPLICABLE LAW OR REGULATION OF OR WOULD REQUIRE ANY REGISTRATION OR LICENCING WITHIN SUCH JURISDICTION. Regulated information1 Materialise NV ((Euronext &, NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced the start of its additional listing of its ordinary shares on Euronext Brussels, to complement the existing Na
Cantor Fitzgerald initiated coverage of Materialise with a rating of Overweight and set a new price target of $9.50
Kepler upgraded Materialise from Hold to Buy and set a new price target of $11.00
Bryan Garnier downgraded Materialise from Buy to Neutral and set a new price target of $20.00
Fried Vancraen, Co-founder and CEO, to become Chairman of the Board Materialise NV (NASDAQ:MTLS), a global leader in 3D printing software and services, today announced that the company's Board of Directors has appointed Brigitte de Vet-Veithen as Chief Executive Officer. Brigitte de Vet-Veithen will succeed Fried Vancraen, who co-founded Materialise in 1990 and has served as the company's CEO for 33 years. Mr. Vancraen will continue to represent Materialise as the new Chairman of the Board of Directors. The leadership transition will become effective on January 1, 2024, as part of the management changes described below. "We founded Materialise with a mission to create a better and healt
Regulated information1 Materialise NV ((Euronext &, NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Materialise Medical segment. Gross profit as a percentage of revenue for the fourth quarter of 2025 increased to 58.1%, compared to 55.4% for the corresponding 2024 period. Adjusted EBIT amounted to 3,98
Materialise NV ((Euronext &, NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the fourth quarter ended December 31, 2025 on Thursday, February 19, 2026 at 2:30 a.m. ET/8:30 a.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2025 financial results on Thursday, February 19, 2026 at 8:30 a.m. ET/1:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a
Materialise NV (NASDAQ:MTLS), a global leader in 3D-printed medical devices and software and a pioneer in additive manufacturing software and services, today announced its financial results for the third quarter ended September 30, 2025. Highlights – Third Quarter 2025 Total consolidated revenue increased 2.2% to 66,259 kEUR compared to the second quarter of 2025, but decreased 3.5% compared to the third quarter of 2024. Revenue from our Materialise Medical segment grew 10.3% compared to the corresponding 2024 period. Gross profit as a percentage of revenue for the third quarter of 2025 was 56.8%, in line with the gross margin realized over the first nine months of 2025. Adjusted
SC 13G/A - MATERIALISE NV (0001091223) (Subject)
SC 13G/A - MATERIALISE NV (0001091223) (Subject)
SC 13G/A - MATERIALISE NV (0001091223) (Subject)